About

Insugen 30/70 is a biphasic insulin preparation containing 30% soluble insulin (rapid-acting) and 70% isophane insulin (intermediate-acting). This combination is designed to provide both a rapid onset of action to cover post-meal glucose spikes and a sustained effect to manage basal glucose levels. It is indicated for the treatment of diabetes mellitus in patients requiring insulin therapy to maintain adequate glycemic control. The soluble insulin component starts working within 30 minutes, while the isophane insulin component provides a longer duration of action, typically lasting up to 24 hours. This formulation helps to mimic the body's natural insulin release pattern, addressing both prandial and basal insulin needs with fewer injections. Careful adherence to administration instructions and blood glucose monitoring are crucial for optimal outcomes and to prevent hypoglycemia.

Uses

Management of type 1 diabetes.
Management of type 2 diabetes.
To control post-meal blood glucose.
To provide sustained basal insulin.

Directions For Use

Administer subcutaneously 30 minutes before a meal. Rotate injection sites.

Benefits

Provides both rapid and intermediate insulin action.
Covers both post-meal and basal glucose needs.
Reduces the number of daily injections.
Effective for overall glycemic control.
Helps prevent long-term diabetes complications.
Mimics natural insulin release pattern.

Side Effects

Hypoglycemia
Injection site reactions (pain, redness, swelling)
Lipodystrophy
Weight gain
Peripheral edema
Allergic reactions
Pruritus
Rash
Urticaria
Blurred vision (transient)
Headache
Nausea

Safety Measures

Alcohol - Alcohol can lower blood sugar and increase the risk of hypoglycemia. Use with caution and monitor blood glucose.
Pregnancy - Generally considered safe for use during pregnancy. Close monitoring of blood glucose is essential.
Breastfeeding - Insulin is not excreted into breast milk and is safe for use while breastfeeding.
Liver - Dose adjustments may be necessary in patients with hepatic impairment due to altered insulin metabolism.
Kidney - Dose adjustments may be required in patients with renal impairment due to reduced insulin clearance.
Lung - No specific contraindications or precautions related to lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.

Shipping & Location